While selective serotonin reuptake inhibitors (SSRIs) remain the most commonly prescribed class of antidepressants, many physicians and patients express concerns about the risks of bleeding associated with these medications. It is thought that this risk is due to reduction in platelets’ serotonin, which impairs their role in clotting (Anglin et al. 2014). There is also evidence that SSRI use increases gastric acidity, promoting gastritis and peptic ulcers and associated gastrointestinal (GI) bleeding (Andrade and Sharma 2016).